XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 93 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $586,358 | -44.9% | 315,246 | -22.4% | 0.13% | -42.5% |
| Q2 2023 | $1,064,218 | +5.0% | 406,190 | -34.7% | 0.23% | -6.8% |
| Q1 2023 | $1,013,977 | +106.7% | 622,072 | +68.6% | 0.25% | +78.6% |
| Q4 2022 | $490,672 | -41.5% | 368,926 | -31.4% | 0.14% | -32.0% |
| Q3 2022 | $839,000 | +34.2% | 537,926 | +32.5% | 0.21% | +41.1% |
| Q2 2022 | $625,000 | -1.6% | 406,000 | +63.7% | 0.15% | +35.2% |
| Q1 2022 | $635,000 | -47.3% | 248,000 | -39.7% | 0.11% | -44.9% |
| Q4 2021 | $1,204,000 | – | 411,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $15,460,000 | 19.22% |
| Stonepine Capital Management, LLC | 7,924,056 | $20,286,000 | 8.41% |
| ARMISTICE CAPITAL, LLC | 7,464,993 | $19,110,000 | 0.37% |
| NEA Management Company, LLC | 3,246,785 | $8,312,000 | 0.24% |
| Alpine Global Management, LLC | 633,040 | $1,620,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 248,000 | $635,000 | 0.11% |
| Redmile Group, LLC | 1,046,587 | $2,679,000 | 0.08% |
| CTC Capital Management, LLC | 11,800 | $30,000 | 0.08% |
| TUDOR INVESTMENT CORP ET AL | 961,192 | $2,461,000 | 0.06% |
| Yakira Capital Management, Inc. | 117,076 | $300,000 | 0.04% |